Logo image of ZCAR

ZOOMCAR HOLDINGS INC (ZCAR) Stock Fundamental Analysis

NASDAQ:ZCAR - Nasdaq - US45784G2003 - Common Stock

2  +0.01 (+0.5%)

After market: 1.98 -0.02 (-1%)

Fundamental Rating

1

Overall ZCAR gets a fundamental rating of 1 out of 10. We evaluated ZCAR against 38 industry peers in the Ground Transportation industry. ZCAR may be in some trouble as it scores bad on both profitability and health. ZCAR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ZCAR was profitable.
In the past year ZCAR has reported a negative cash flow from operations.
ZCAR Yearly Net Income VS EBIT VS OCF VS FCFZCAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

The Return On Assets of ZCAR (44.72%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 44.72%
ROE N/A
ROIC N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZCAR Yearly ROA, ROE, ROICZCAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

ZCAR has a Profit Margin of 52.45%. This is amongst the best in the industry. ZCAR outperforms 100.00% of its industry peers.
The Operating Margin and Gross Margin are not available for ZCAR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 52.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZCAR Yearly Profit, Operating, Gross MarginsZCAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -100 -200 -300

0

2. Health

2.1 Basic Checks

ZCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZCAR has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ZCAR has a worse debt to assets ratio.
ZCAR Yearly Shares OutstandingZCAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
ZCAR Yearly Total Debt VS Total AssetsZCAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -66.70, we must say that ZCAR is in the distress zone and has some risk of bankruptcy.
ZCAR has a worse Altman-Z score (-66.70) than 97.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -66.7
ROIC/WACCN/A
WACC6.38%
ZCAR Yearly LT Debt VS Equity VS FCFZCAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.11 indicates that ZCAR may have some problems paying its short term obligations.
ZCAR has a Current ratio of 0.11. This is amonst the worse of the industry: ZCAR underperforms 97.37% of its industry peers.
A Quick Ratio of 0.11 indicates that ZCAR may have some problems paying its short term obligations.
ZCAR has a worse Quick ratio (0.11) than 97.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
ZCAR Yearly Current Assets VS Current LiabilitesZCAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

ZCAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1646.48%, which is quite impressive.
EPS 1Y (TTM)1646.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6225.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCAR Yearly Revenue VS EstimatesZCAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M
ZCAR Yearly EPS VS EstimatesZCAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.65, the valuation of ZCAR can be described as very cheap.
Based on the Price/Earnings ratio, ZCAR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ZCAR to the average of the S&P500 Index (28.29), we can say ZCAR is valued rather cheaply.
Industry RankSector Rank
PE 0.65
Fwd PE N/A
ZCAR Price Earnings VS Forward Price EarningsZCAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZCAR Per share dataZCAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZCAR!.
Industry RankSector Rank
Dividend Yield N/A

ZOOMCAR HOLDINGS INC

NASDAQ:ZCAR (1/21/2025, 8:00:02 PM)

After market: 1.98 -0.02 (-1%)

2

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.96%
Inst Owner Change-1.88%
Ins Owners11.52%
Ins Owner Change0%
Market Cap4.12M
AnalystsN/A
Price TargetN/A
Short Float %10.82%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.65
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.09
EY154.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-11.46
FCFYN/A
OCF(TTM)-11.39
OCFYN/A
SpS3.32
BVpS-15.28
TBVpS-15.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 44.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 52.45%
GM N/A
FCFM N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -66.7
F-Score6
WACC6.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1646.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-6225.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-206.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3968.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3943.7%
OCF growth 3YN/A
OCF growth 5YN/A